EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Precise HER2 Protein Degradation via Peptide‐Conjugated Photodynamic Therapy for Enhanced Breast Cancer Immunotherapy

Changyong Guo, Fei Gao, Guoyuan Wu, Jinqiu Li, Chunquan Sheng, Shipeng He iD, Honggang Hu

Advanced Science · 2025

DOI: 10.1002/advs.202410778 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Changyong Guo und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine or Institute of Translational Medicine, Shanghai Engineering Research Center of Organ Repair, Shanghai University, 99 Shangda Road…. Hauptthemen laut MEDLINE: Photochemotherapy, Erb-b2 Receptor Tyrosine Kinases, Breast Neoplasms, Immunotherapy. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Rising-Star Program, Science Fund for Distinguished Young Scholars of Fujian Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer, the most prevalent malignancy among women, frequently exhibits high HER2 expression, making HER2 a critical therapeutic target. Traditional treatments combining the anti‐HER2 antibody trastuzumab with immunotherapy face limitations due to toxicity and tumor microenvironment immunosuppression. This study introduces an innovative strategy combining HER2‐targeting peptides with the photosensitizer (PSs) pyropheophorbide‐a (Pha) via a gelatinase‐cleavable linker, forming self‐assembling nanoparticles. These nanoparticles actively target breast cancer cells and generate reactive oxygen species (ROS) under near‐infrared light, effectively degrading HER2 proteins. Upon internalization, the linker is cleaved, releasing Pha‐PLG and enhancing intracellular photodynamic therapy (PDT). The Pha‐PLG molecules self‐assemble into nanofibers, prolonging circulation, boosting immune induction, and activating CD8 + T cells, thus promoting a robust anti‐tumor immune response. In vivo, studies confirm superior biosafety, tumor targeting, and HER2 degradation, with increased cytotoxic T cell activity and improved antitumor immunity. This integrated strategy offers a promising new avenue for breast cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhotochemotherapyErb-b2 Receptor Tyrosine KinasesBreast NeoplasmsImmunotherapyPeptidesFemaleAnimalsMiceHumansPhotosensitizing AgentsCell Line, TumorChlorophyllReactive Oxygen SpeciesMice, Inbred BALB CNanoparticles

Stichwörter der Autor:innen

breast cancergelatinase responsive peptidesimmune inductionphotodynamic immunotherapyphoto‐controlled her2 protein degradation

Substanzen

Erb-b2 Receptor Tyrosine KinasesPhotosensitizing AgentsPeptidesChlorophyllReactive Oxygen SpeciesERBB2 protein, humanpyropheophorbide a

Autor:innen und Institutionen

  • School of Medicine or Institute of Translational Medicine, Shanghai Engineering Research Center of Organ Repair, Shanghai University, 99 Shangda Road, Shanghai, 200444, P. R. China.
  • The Center for Basic Research and Innovation of Medicine and Pharmacy (MOE), School of Pharmacy, Second Military Medical University (Naval Medical University), 325 Guohe Road, Shanghai, 200433, P. R. China.

ORCID-Profile: Shipeng He

Förderung

  • National Natural Science Foundation of China
  • Shanghai Rising-Star Program
  • Science Fund for Distinguished Young Scholars of Fujian Province
  • Key Technologies Research and Development Program

Zitieren

APA

Guo, C., Gao, F., Wu, G., Li, J., Sheng, C., He, S., & Hu, H. (2025). Precise HER2 Protein Degradation via Peptide‐Conjugated Photodynamic Therapy for Enhanced Breast Cancer Immunotherapy. Advanced Science. https://doi.org/10.1002/advs.202410778

Vancouver

Guo C, Gao F, Wu G, Li J, Sheng C, He S, et al. Precise HER2 Protein Degradation via Peptide‐Conjugated Photodynamic Therapy for Enhanced Breast Cancer Immunotherapy. Advanced Science. 2025. doi:10.1002/advs.202410778

BibTeX
@article{Guo2025,
  author = {Guo, Changyong and Gao, Fei and Wu, Guoyuan and Li, Jinqiu and Sheng, Chunquan and He, Shipeng and Hu, Honggang},
  title = {Precise HER2 Protein Degradation via Peptide‐Conjugated Photodynamic Therapy for Enhanced Breast Cancer Immunotherapy},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202410778}
}
Kostenlos starten →